{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:09:15Z","timestamp":1790096955527,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drudis.2026.104748","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:14:49Z","timestamp":1785132889000},"page":"104748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interplay between RNA m6A modification and transglutaminase 2 inhibitor effects on mitophagy dysfunction in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Ankita","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shareen","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amritpal","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3956-1898","authenticated-orcid":false,"given":"Sukriti","family":"Vishwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104748_b0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2026.104748_b0010","unstructured":"World Health Organization. Dementia. Accessed 24 May 2026. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"10.1016\/j.drudis.2026.104748_b0015","unstructured":"Alzheimer\u2019s Disease International. Dementia statistics. Accessed 15 May 2026. https:\/\/www.alzint.org\/about\/dementia-facts-figures\/dementia-statistics\/."},{"key":"10.1016\/j.drudis.2026.104748_b0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104748_b0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"},{"key":"10.1016\/j.drudis.2026.104748_b0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41398-026-03947-1","article-title":"Beyond microtubule regulation: the multifaceted roles of tau in neuronal function and dysfunction","volume":"16","author":"Bakota","year":"2026","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.drudis.2026.104748_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahr.2023.100169","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease\u2014a step towards mitochondria based therapeutic strategies","volume":"3","author":"Aran","year":"2023","journal-title":"Aging Health Res"},{"key":"10.1016\/j.drudis.2026.104748_b0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104748_b0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovi\u0107","year":"2013","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.drudis.2026.104748_b0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2014too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2026.104748_b0055","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fphar.2019.00902","article-title":"Mitochondria as potential targets in Alzheimer disease therapy: an update","volume":"10","author":"Cenini","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2026.104748_b0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2026.104748_b0065","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2021.3854","article-title":"Evaluation of aducanumab for Alzheimer disease: scientific evidence and regulatory review involving efficacy, safety, and futility","volume":"325","author":"Alexander","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2026.104748_b0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","article-title":"The pathways of mitophagy for quality control and clearance of mitochondria","volume":"20","author":"Ashrafi","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.drudis.2026.104748_b0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.drudis.2026.104748_b0080","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/alz.12198","article-title":"Mitophagy alterations in Alzheimer\u2019s disease are associated with granulovacuolar degeneration and early tau pathology","volume":"17","author":"Hou","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.drudis.2026.104748_b0085","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00726-011-1018-8","article-title":"Monitoring of transglutaminase 2 under different oxidative stress conditions","volume":"42","author":"Caccamo","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.drudis.2026.104748_b0090","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3858\/emm.2010.42.9.063","article-title":"Transglutaminase 2 inhibits apoptosis induced by calcium-overload through down-regulation of Bax","volume":"42","author":"Cho","year":"2010","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.drudis.2026.104748_b0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/cells11030389","article-title":"The transglutaminase-2 interactome in the APP23 mouse model of Alzheimer\u2019s disease","volume":"11","author":"Wilhelmus","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104748_b0100","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104748_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13059-020-02249-z","article-title":"N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer\u2019s disease","volume":"22","author":"Shafik","year":"2021","journal-title":"Genome Biol"},{"key":"10.1016\/j.drudis.2026.104748_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fnins.2020.00098","article-title":"Abnormality of m6A mRNA methylation is involved in Alzheimer\u2019s disease","volume":"14","author":"Han","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.drudis.2026.104748_b0115","first-page":"231","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2026.104748_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102713","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"107","author":"D\u2019Alessandro","year":"2025","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.drudis.2026.104748_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease","volume":"13","author":"Misrani","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2026.104748_b0130","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.2147\/JIR.S483412","article-title":"Prevention and treatment strategies for Alzheimer\u2019s disease: focusing on microglia and astrocytes in neuroinflammation","volume":"17","author":"Zhang","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.drudis.2026.104748_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117144","article-title":"Phytochemicals targeting mitophagy: therapeutic opportunities and prospects for treating Alzheimer\u2019s disease","volume":"177","author":"Yang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104748_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.684398","article-title":"Melatonin attenuates chromium (VI)-induced spermatogonial stem cell\/progenitor mitophagy by restoration of METTL3-mediated RNA N6-methyladenosine modification","volume":"9","author":"Lv","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.drudis.2026.104748_b0145","article-title":"RNA N6-methyladenosine modifications and its roles in Alzheimer\u2019s disease","volume":"16","author":"Zhang","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.drudis.2026.104748_b0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13024-021-00484-x","article-title":"METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer\u2019s disease through aberrant cell cycle events","volume":"16","author":"Zhao","year":"2021","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.drudis.2026.104748_b0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.62347\/AOSK8903","article-title":"Regulatory mechanisms of m6A methylation in dilated cardiomyopathy","volume":"17","author":"Zhang","year":"2025","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.drudis.2026.104748_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002017","article-title":"Loss of the m6A methyltransferase METTL3 in monocyte-derived macrophages ameliorates Alzheimer\u2019s disease pathology in mice","volume":"21","author":"Yin","year":"2023","journal-title":"PLoS Biol"},{"key":"10.1016\/j.drudis.2026.104748_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107098","article-title":"Single-cell and spatial transcriptomics reveals that PTPRG activates the m6A methyltransferase VIRMA to block mitophagy-mediated neuronal death in Alzheimer\u2019s disease","volume":"201","author":"Zou","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2026.104748_b0170","first-page":"256","article-title":"Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation","volume":"576","author":"Lee","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104748_b0175","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0125-20.2020","article-title":"Altered expression of the m6A methyltransferase METTL3 in Alzheimer\u2019s disease","volume":"7","author":"Huang","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.drudis.2026.104748_b0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.freeradbiomed.2022.12.099","article-title":"KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer\u2019s disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1","volume":"195","author":"Tang","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2026.104748_b0185","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1016\/j.molcel.2021.07.038","article-title":"Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy","volume":"81","author":"Jiang","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2026.104748_b0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/WNR.0000000000001550","article-title":"The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6\/NF-\u03baB pathway","volume":"33","author":"Wen","year":"2022","journal-title":"Neuroreport"},{"key":"10.1016\/j.drudis.2026.104748_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2025.105964","article-title":"METTL3\/IGF2BP2\/I\u03baB\u03b1 axis participates in neuroinflammation in Alzheimer\u2019s disease by regulating M1\/M2 polarization of microglia","volume":"186","author":"Zhu","year":"2025","journal-title":"Neurochem Int"},{"key":"10.1016\/j.drudis.2026.104748_b0200","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12974-021-02205-z","article-title":"The potential roles of m6A modification in regulating the inflammatory response in microglia","volume":"18","author":"Li","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.drudis.2026.104748_b0205","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12974-024-03248-8","article-title":"Advanced paternal age exacerbates neuroinflammation in offspring via m6A modification-mediated intergenerational inheritance","volume":"21","author":"Mao","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.drudis.2026.104748_b0210","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4103\/NRR.NRR-D-23-01872","article-title":"The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases","volume":"20","author":"Li","year":"2025","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.drudis.2026.104748_b0215","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3390\/cells14221820","article-title":"The m6A modification in neurodegenerative disease: a cellular perspective","volume":"14","author":"Wang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104748_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114583","article-title":"Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents","volume":"162","author":"Lv","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104748_b0225","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbamcr.2011.09.012","article-title":"Transglutaminase 2: a molecular Swiss army knife","volume":"1823","author":"Gundemir","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2026.104748_b0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1152\/physrev.00003.2023","article-title":"Tissue transglutaminase: a multifunctional and multisite regulator in health and disease","volume":"104","author":"Yao","year":"2024","journal-title":"Physiol Rev"},{"key":"10.1016\/j.drudis.2026.104748_b0235","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2741\/4536","article-title":"Tissue transglutaminase (TG2) and mitochondrial function and dysfunction","volume":"22","author":"Lai","year":"2017","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.drudis.2026.104748_b0240","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/cdd.2012.2","article-title":"Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins","volume":"19","author":"D\u2019Eletto","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.drudis.2026.104748_b0245","doi-asserted-by":"crossref","first-page":"44941","DOI":"10.18632\/oncotarget.6759","article-title":"The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation","volume":"6","author":"Altuntas","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104748_b0250","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/cdd.2014.106","article-title":"Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis","volume":"22","author":"Rossin","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.drudis.2026.104748_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169161","article-title":"Mitophagy in neurons: mechanisms regulating mitochondrial turnover and neuronal homeostasis","volume":"437","author":"Basak","year":"2025","journal-title":"J Mol Biol"},{"key":"10.1016\/j.drudis.2026.104748_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114596","article-title":"TG2 promotes amyloid beta aggregates: impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer\u2019s disease","volume":"162","author":"Panes-Fernandez","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104748_b0265","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12796","article-title":"Absence of tissue transglutaminase reduces amyloid-beta pathology in APP23 mice","volume":"48","author":"Wilhelmus","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.drudis.2026.104748_b0270","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10863-024-10036-9","article-title":"METTL14 inhibits A\u03b21-42-induced neuronal injury through regulating the stability of CBLN4 mRNA in Alzheimer\u2019s disease","volume":"56","author":"Mu","year":"2024","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.drudis.2026.104748_b0275","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnen\/nlae010","article-title":"METTL3 confers protection against mitochondrial dysfunction and cognitive impairment in an Alzheimer disease mouse model by upregulating Mfn2 via N6-methyladenosine modification","volume":"83","author":"Chen","year":"2024","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.drudis.2026.104748_b0280","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170166","article-title":"Region-specific RNA m6A methylation represents a new layer of control in the gene regulatory network in the mouse brain","volume":"7","author":"Chang","year":"2017","journal-title":"Open Biol"},{"key":"10.1016\/j.drudis.2026.104748_b0285","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/antiox12030750","article-title":"Effect of astaxanthin on tissue transglutaminase and cytoskeletal protein expression in amyloid-beta stressed olfactory ensheathing cells: molecular and delayed luminescence studies","volume":"12","author":"Campisi","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.drudis.2026.104748_b0290","doi-asserted-by":"crossref","first-page":"10766","DOI":"10.3390\/ijms231810766","article-title":"Novel roles of RNA m6A methylation regulators in the occurrence of Alzheimer\u2019s disease and the subtype classification","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104748_b0295","doi-asserted-by":"crossref","first-page":"298","DOI":"10.31083\/j.fbl2908298","article-title":"METTL14-mediated m6A modification of TUG1 represses ferroptosis in Alzheimer\u2019s disease via inhibiting GDF15 ubiquitination","volume":"29","author":"Gu","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.drudis.2026.104748_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.890134","article-title":"Methyltransferase-like 3 rescues the amyloid-beta protein-induced reduction of activity-regulated cytoskeleton associated protein expression via YTHDF1-dependent N6-methyladenosine modification","volume":"14","author":"Xu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2026.104748_b0305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40035-023-00386-6","article-title":"N6-methyladenosine-modified circRIMS2 mediates synaptic and memory impairments by activating GluN2B ubiquitination in Alzheimer\u2019s disease","volume":"12","author":"Wang","year":"2023","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.drudis.2026.104748_b0310","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5483\/BMBRep.2018.51.1.227","article-title":"New insight into transglutaminase 2 and link to neurodegenerative diseases","volume":"51","author":"Min","year":"2018","journal-title":"BMB Rep"},{"key":"10.1016\/j.drudis.2026.104748_b0315","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.celrep.2018.11.094","article-title":"Transglutaminase type 2 regulates ER-mitochondria contact sites by interacting with GRP75","volume":"25","author":"D\u2019Eletto","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2026.104748_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102453","article-title":"Ca2+ handling at the mitochondria-ER contact sites in neurodegeneration","volume":"98","author":"Lim","year":"2021","journal-title":"Cell Calcium"},{"key":"10.1016\/j.drudis.2026.104748_b0325","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3390\/ijms25042364","article-title":"Pathogenetic contributions and therapeutic implications of transglutaminase 2 in neurodegenerative diseases","volume":"25","author":"Liu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104748_b0330","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/emmm.201000084","article-title":"Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease","volume":"2","author":"McConoughey","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.drudis.2026.104748_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101034","article-title":"Potential of natural drug modulation of endoplasmic reticulum stress in the treatment of myocardial injury","volume":"14","author":"Yang","year":"2024","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.drudis.2026.104748_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1422686","article-title":"Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality","volume":"15","author":"Pang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2026.104748_b0345","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","article-title":"Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction","volume":"27","author":"Pang","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.drudis.2026.104748_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157288","article-title":"Astragaloside VI attenuates mechanical stress-induced cardiac remodeling through Piezo1-VDAC1 dependent endoplasmic reticulum unfolded protein response","volume":"148","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drudis.2026.104748_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156982","article-title":"Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury","volume":"145","author":"Pu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drudis.2026.104748_b0360","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/ptr.70008","article-title":"Potential candidates of natural antioxidants from herbs for treating lung disorders: focus on redox balance and natural products","volume":"39","author":"Chang","year":"2025","journal-title":"Phytother Res"},{"key":"10.1016\/j.drudis.2026.104748_b0365","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"DNA-PKcs-driven YAP1 phosphorylation and nuclear translocation: a key regulator of ferroptosis in hyperglycemia-induced cardiac dysfunction in type 1 diabetes","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.drudis.2026.104748_b0370","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.7150\/ijbs.102424","article-title":"Targeting mitochondria by lipid-selenium conjugate drug results in malate\/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression","volume":"20","author":"Chang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.drudis.2026.104748_b0375","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12951-025-03667-6","article-title":"A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5-DUSP1 axis for mitochondrial repair","volume":"23","author":"Shi","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.drudis.2026.104748_b0380","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fnagi.2019.00311","article-title":"Dysfunctional mitochondria and mitophagy as drivers of Alzheimer\u2019s disease pathogenesis","volume":"11","author":"Chakravorty","year":"2019","journal-title":"Front Aging Neurosci"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:22:44Z","timestamp":1790094164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626001534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1359644626001534"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104748","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay between RNA m6A modification and transglutaminase 2 inhibitor effects on mitophagy dysfunction in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104748"}}